Use Case · Healthcare
Clinical Decision Support & Diagnostics—Without AI Accessing Patient Identity
The Veil enables healthcare organisations to deploy AI for clinical decision support, diagnostic assistance, and population health analytics on pseudonymised medical records so the model never sees patient names, NHS numbers, or insurance identifiers. The architecture aligns with the privacy-by-design and data-minimisation measures GDPR Article 9, MDR Annex VIII Rule 11, and national health data rules expect — architectural alignment, not a held certification.
The Privacy Barrier to Healthcare AI
Health data falls under GDPR Article 9 as a special category requiring explicit consent or a specific legal basis for processing. Clinical AI systems often need rich patient histories to provide useful support, yet every additional data point increases the severity of a potential breach. A single compromised diagnostic AI could expose thousands of patient records including conditions, medications, and genetic markers.
The Medical Device Regulation (MDR) adds another layer: AI systems providing clinical decision support may qualify as medical devices (MDR Annex VIII, Rule 11), bringing post-market surveillance and risk management obligations. The Veil addresses both privacy and device safety by ensuring the AI component only ever processes pseudonymised feature sets.
How The Veil Works for Healthcare
| Stage | What Happens | Where |
|---|---|---|
| 1. Ingestion | Clinical records enter Sandbox A. Patient names, NHS/insurance numbers, dates of birth, and addresses are replaced with cryptographic tokens. Clinical content (symptoms, lab values, imaging features) passes through. | Sandbox A (PII) |
| 2. AI Analysis | Pseudonymised feature sets flow to Sandbox B. The AI model provides diagnostic support, treatment recommendations, or population analytics—all on tokens, never on patient identities. | Sandbox B (AI) |
| 3. Clinical Output | AI returns diagnostic suggestions, risk stratifications, or cohort analyses attached to tokens. No patient-identifiable information exists in Sandbox B at any point. | Sandbox B (AI) |
| 4. Re-linkage | For treatment decisions: tokens are re-linked to patient identity inside Sandbox A via a break-glass mechanism. Re-linkage requires clinician authorisation and creates a full audit trail. | Bridge (controlled) |
Healthcare AI Use Cases
Clinical Decision Support
AI analyses pseudonymised clinical features—symptom clusters, lab result ranges, medication histories represented as coded tokens—to suggest differential diagnoses or flag drug interactions. The treating clinician sees the AI output linked back to their patient only after re-linkage.
- Differential diagnosis suggestions based on coded symptom patterns
- Drug interaction alerts using tokenised medication lists
- Treatment protocol matching without exposing patient demographics to the model
Diagnostic Assistance with Pseudonymised Records
Medical imaging features, pathology results, and genomic markers are extracted and tokenised before the diagnostic model processes them. The AI operates on abstract feature vectors: "Token-9b2e presents feature pattern consistent with Stage II indicators"—never "Jane Doe has a tumour."
- Imaging analysis on de-identified DICOM data with stripped patient headers
- Pathology pattern recognition on tokenised tissue sample data
- Genomic risk scoring where the AI never sees the individual behind the genome
Population Health Analytics on De-Identified Cohorts
Aggregate analysis across thousands of pseudonymised patient records enables population health insights—disease prevalence trends, treatment outcome comparisons, resource allocation modelling—without any individual patient being identifiable within the AI environment.
- Epidemiological trend analysis on token-level cohort data
- Treatment efficacy comparisons across pseudonymised patient groups
- Hospital resource planning using anonymised demand patterns
Regulatory Alignment Mapping
| Regulation | Requirement | The Veil Response |
|---|---|---|
| GDPR Art. 9(1) | Prohibition on processing special category data without explicit basis | AI sandbox processes pseudonymised feature sets, not identifiable health data—reducing the legal basis burden for the AI processing layer |
| GDPR Art. 9(2)(h) | Processing for preventive or occupational medicine | Re-linkage for clinical action falls under healthcare provision basis; AI analysis itself operates on non-identifiable tokens |
| GDPR Art. 35 | Data Protection Impact Assessment | The Veil’s architectural separation significantly reduces DPIA risk scores by eliminating identity exposure in the AI processing environment |
| MDR Annex VIII, Rule 11 | Classification of software providing diagnostic information | The Veil isolates the AI component; risk management documentation demonstrates patient identity is architecturally excluded from the device boundary |
| MDR Art. 10(9) | Post-market surveillance | Audit trails in the bridge layer provide full traceability of AI outputs and re-linkage events for regulatory reporting |
| National Health Data Laws | Jurisdiction-specific requirements (e.g., UK Data Protection Act 2018 Schedule 1, German BDSG §22) | The Veil’s pseudonymisation layer architecturally aligns with the “appropriate safeguards” language present in most national health data frameworks — architectural alignment, not a jurisdiction-specific certification |
These are architectural and evidence-layer alignments, not held certifications. Certification roadmap available on request.
Break-Glass Re-Linkage for Clinical Decisions
Healthcare demands faster re-linkage than other sectors. The Veil supports a break-glass mechanism for time-critical clinical scenarios:
- Authorised clinician triggers re-linkage with role-based credentials
- Every break-glass event is logged with timestamp, clinician ID, patient token, and clinical justification
- Post-hoc review workflow alerts the data protection officer for audit within 24 hours
- Re-linkage scope is limited to the specific token(s) relevant to the clinical decision—no bulk de-pseudonymisation
Breach Scenario: What an Attacker Gets
If an attacker compromises the AI sandbox (Sandbox B), they obtain:
- Clinical insights and diagnostic suggestions attached to meaningless cryptographic tokens
- Population health statistics with no path to individual patient identification
- Treatment recommendation models that reference token IDs, not people
No patient names. No NHS numbers. No insurance identifiers. No dates of birth. The token-to-patient mapping exists only in Sandbox A, behind a separate security boundary.
Key Takeaways for Healthcare CISOs
- GDPR Article 9 special category requirements are addressed by ensuring the AI layer never processes identifiable health data
- MDR device boundary analysis is simplified when patient identity is architecturally excluded from the AI component
- Break-glass re-linkage provides the speed clinicians need while maintaining full audit trails for regulators
- A breach of the AI environment yields clinical patterns attached to tokens—zero patient identification risk
- Fully local / air-gapped deployment is the recommended default: Sandbox B runs Ollama or vLLM inside the hospital Kubernetes cluster with no egress to external LLM providers—raw identity data never leaves your environment, and in split deployment only sanitized text, opaque pseudonymous tokens, and content hashes cross infrastructure boundaries